Status:
NOT_YET_RECRUITING
Long Term Follow-up Grafted Huntington's Disease Patients
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Huntington Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Long-term follow-up of Huntington's disease patients treated with intrastriatal allografts is essential to assess the benefit/risk ratio of grafts as well as their effectiveness. Indeed, some patients...
Detailed Description
The aim is to create a specific cohort of transplant patients, to homogenise their follow-up methods, to collect all the patient data (medical, paramedical, imaging, biological) acquired from the end ...
Eligibility Criteria
Inclusion
- Adult patients transplanted under the MIG-HD protocol
- Information and informed consent from patients or their representative
- Affiliation with a social security scheme or beneficiary
Exclusion
- Patient under AME
- Patient unable to express consent and not subject to legal protection
- Knowned pregnancy or breastfeeding woman
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2034
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06194006
Start Date
January 1 2024
End Date
January 1 2034
Last Update
January 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Paris - Hôpital Henri Mondor
Créteil, France, 94010